Quantcast
US Market Closed
Oct 18,2018
NIKKEI 225  22532.08
-126.08 ▼-0.56%
OMXN40  1454.45
-16.6 ▼-1.13%
FTSE100  6859.15
-34.77 ▼-0.5%

Stock Market Overview

Index Value Change Net / %
Data as of Oct 18, 2018
 


Stock Market News & Analysis


Stock Activity

Company Last Sale* Change Net / % Share Volume
$10.35 8.46 ▲ 447.62% 82,835,974
$26.62 0.68 ▼ 2.49% 77,847,712
$173.18 4.11 ▼ 2.32% 77,145,231
$13.38 0.85 ▲ 6.78% 45,832,125
$23.40 7.84 ▲ 50.39% 35,657,995
As of 10/18/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$10.35 8.46 ▲ 447.62% 82,835,974
$23.40 7.84 ▲ 50.39% 35,657,995
$15.49 2.50 ▲ 19.25% 165,643
$8.50 1.02 ▲ 13.63% 8,311
$41.95 4.81 ▲ 12.95% 26,858,436
As of 10/18/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$27.18 6.50 ▼ 19.30% 525,363
$29.49 6.39 ▼ 17.81% 19,759,932
$13.86 2.85 ▼ 17.06% 1,535,944
$26.90 5.50 ▼ 16.98% 1,013,911
$13.71 2.32 ▼ 14.47% 222,768
As of 10/18/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$173.18 4.11 ▼ 2.32% 82,085,643
$1,770.72 61.01 ▼ 3.33% 5,838,215
$216.02 5.17 ▼ 2.34% 32,422,530
$346.71 17.99 ▼ 4.93% 18,391,493
$108.50 2.21 ▼ 2.00% 31,626,273
As of 10/18/2018 4:00:00 PM

Company Last Sale Price Change Net / % Share Volume Volume % Change
$10.35 8.46 ▲ 447.62% 93,983,778 66574%
$23.40 7.84 ▲ 50.39% 46,788,841 3085%
$11.75 1.55 ▲ 15.20% 8,281,690 941%
$38.57 2.80 ▲ 7.83% 8,366,065 560%
$52.24 2.66 ▲ 5.37% 684,474 379%
As of 10/18/2018 4:15:00 PM

Upcoming IPOs

Name Price Range
TWIST BIOSCIENCE CORP $14.00 - $16.00
ETON PHARMACEUTICALS, $6.00
STONECO LTD. $21.00 - $23.00

Earnings

Earnings Calendar

Visit Earnings Calendar for the week starting 10/14; 101 reports are scheduled.

Company Last Sale* Change Net / %
PG$80.241.62 ▼ 1.98%

Recommendations

Forecasts

Surprises


ETFs

Decliners

Advancers


Today at Nasdaq







Market Musings

Martin Tillier's daily read on the markets.

Martin Tillier

The Week in ETFs

A weekly briefing on major news, trends and players shaping the world of ETFs.



Investing Ideas

Richard Saintvilus offers actionable investing insights.

x